TELA Bio, Inc. (NASDAQ:TELA) Q2 2025 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to TELA Bio's Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded.
Tela Bio Inc. (TELA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 5,111,588 | $9,916,481 | +32% | 0.39% |
| 2. | SilverArc Capital Devesh Gandhi | 2,779,795 | $5,392,802 | +1% | 0.99% |
| 3. | Stonepine Capital Timothy P. Lynch | 2,083,762 | $4,042,498 | +2% | 3.97% |
| 4. | DAFNA Capital Management Nathan Fischel | 1,441,029 | $2,795,596 | 0.77% | |
| 5. | Pentwater Capital Management Matthew Halbower | 815,000 | $1,581,100 | -19% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.25 | 64,444 | $144,999.00 | 155,388 | 2024-10-24 | Filing | |
| $2.25 | 22,222 | $49,999.50 | 91,082 | 2024-10-24 | Filing | |
| $2.25 | 88,888 | $199,998.00 | 458,897 | 2024-10-24 | Filing | |
| $2.25 | 6,666 | $14,998.50 | 57,279 | 2024-10-24 | Filing | |
| $8.01 | 5,000 | $40,050.00 | 3,610,709 | 2022-07-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.54 | 36,600 | $166,164.00 | 2,407,242 | 2024-07-02 | Filing | |
| $4.68 | 13,700 | $64,116.00 | 2,443,842 | 2024-07-01 | Filing | |
| $4.74 | 378,000 | $1,791,720.00 | 2,457,542 | 2024-06-28 | Filing | |
| $9.41 | 27,700 | $260,657.00 | 2,835,542 | 2023-04-21 | Filing | |
| $9.43 | 28,300 | $266,869.00 | 2,863,242 | 2023-04-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,110,709 | $7,974,775 | 2.86% | |
| 2. | 1,911,578 | $3,708,462 | 0% | |
| 3. | 875,865 | $1,699,178 | 1.71% | |
| 4. | 750,000 | $1,455,000 | 0% | |
| 5. | 458,506 | $889,502 | 0% |
News See All
Tela Bio Announces OviTex Inguinal Reinforced Tissue Matri's European Debut
According to TELA Bio, Inc.
TELA Bio, Inc. (NASDAQ:TELA) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the TELA Bio First Quarter 2025 Earnings Conference Call. At this time, all participants are in listen-only mode.
TELA Bio, Inc. (NASDAQ:TELA) Q4 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the TELA Bio Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
TELA Bio, Inc. (NASDAQ:TELA) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the TELA Bio Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
TELA Bio, Inc. (NASDAQ:TELA) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the TELA Bio Second Quarter 2024 Earnings Conference Call. [Operator Instructions].
TELA Bio, Inc. (NASDAQ:TELA) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the TELA Bio First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
TELA Bio, Inc. (NASDAQ:TELA) Q4 2023 Earnings Call Transcript
TELA Bio, Inc. misses on earnings expectations. Reported EPS is $-0.53 EPS, expectations were $-0.44.
5 Oversold Healthcare Stocks To Buy Right Now
In this article, we will be taking a look at 5 oversold healthcare stocks to buy right now.
TELA Bio, Inc. (NASDAQ:TELA) Q3 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by, and welcome to the TELA Bio Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
